Adult HPV vaccination has limited impact
The Costa Rica Vaccine Trial for human papillomavirus in young women has had a “modest” impact on gynecologic outcomes in the first few years of the program. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 22, 2013 Category: Cancer & Oncology Source Type: news
Sleep disturbance persists in women with ovarian cancer
Sleep disturbance appears to be common in women with ovarian cancer and persists for up to 1 year after diagnosis, study findings show. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 16, 2013 Category: Cancer & Oncology Source Type: news
Immunocytochemistry ‘highly accurate’ for ALK detection
Immunocytochemistry is highly accurate for detecting anaplastic lymphoma kinase rearrangements in non-small-cell lung cancers, a study by Swiss researchers has found. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 12, 2013 Category: Cancer & Oncology Source Type: news
Vitamin supplementation unnecessary before pemetrexed
The duration of vitamin supplementation before the first dose of pemetrexed does not appear to influence the risk for treatment toxicity in lung cancer patients, a study has found. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 10, 2013 Category: Cancer & Oncology Source Type: news
PNA clamping outperforms standard EGFR mutation detection
Epidermal growth factor receptor mutations can be reliably detected in a range of lung cancer samples using peptic nucleic acid clamping, South Korean researchers report. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 10, 2013 Category: Cancer & Oncology Source Type: news
Ubiquitin enzymes show lung cancer treatment promise
Deubiquitinating enzymes offer a novel target for the treatment of lung cancer through the receptor tyrosine kinase signaling pathway, scientists say. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 3, 2013 Category: Cancer & Oncology Source Type: news
Surrogate markers aid lung cancer trials
Research suggests that surrogate markers for overall survival are acceptable endpoints for clinical trials of chemotherapy and radiotherapy in patients with lung cancer. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 3, 2013 Category: Cancer & Oncology Source Type: news
Gene mutation clustering limited in NSCLC
Gene mutations in patients with non-small-cell lung cancer show some clustering by ethnicity and histology but are not exclusive to patient subgroups, indicates research by an international team. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 2, 2013 Category: Cancer & Oncology Source Type: news
Pre-op chemo timing no advantage in resectable NSCLC
The timing of chemotherapy in relation to surgery does not appear to influence survival in patients with early-stage non-small-cell lung cancer, a randomized trial has found. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 2, 2013 Category: Cancer & Oncology Source Type: news
Prostatectomy patients ‘should be spared bowel preparation’
Japanese research shows that patients with T1 or T2 prostate cancer who do not undergo mechanical bowel preparation prior to laparoscopic prostatectomy fair no worse than patients who do. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 1, 2013 Category: Cancer & Oncology Source Type: news
Young Black men least likely to undergo prostate cancer screening follow-up
Black men under the age of 65 years are significantly less likely to receive follow-up after an elevated prostate-specific antigen (PSA) test than White men, research shows. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 1, 2013 Category: Cancer & Oncology Source Type: news
NSCLC immunization ‘proof of concept’ achieved
Immunization against MAGE-A3 is a feasible adjuvant treatment in patients with resectable non-small-cell lung cancer expressing the tumor-specific antigen, research suggests. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 1, 2013 Category: Cancer & Oncology Source Type: news
Protein expression could guide NSCLC chemotherapy choice
Protein expression analysis is technically possible as a means of guiding chemotherapy decisions in patients with a new diagnosis of advanced non-small-cell lung cancer, US investigators say. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - July 1, 2013 Category: Cancer & Oncology Source Type: news
Exophytic RCC lesions predict benign histology
Age, gender, and exophytic properties may help clinicians predict benign histology in patients with T1a renal cell carcinomas, suggest findings published in the International Journal of Urology. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 28, 2013 Category: Cancer & Oncology Source Type: news
Best sequence for optimal targeted mRCC therapy remains elusive
The use of targeted therapies for metastatic renal cell carcinoma could see patients surviving in excess of 2 years, suggest findings from the Institut Gustave Roussy in Paris, France. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - June 26, 2013 Category: Cancer & Oncology Source Type: news
